Potential Takeover of Biogaran by Benta Lyon: Government Vigilance and Company Details

The French pharmaceutical laboratory and subcontractor Benta Lyon, based in Saint-Genis-Laval, has “positioned itself” for a possible takeover of the number a -one generic in France, Biogaran, an expert in the pharmaceutical sector told AFP, partially confirming. information from Challenges. Biogaran, which is owned by the French pharmaceutical group Servier and has been the subject of sale rumors for several weeks, was said to have been the recipient “at the end of last week” of an “initial offer of almost 1 billion euros”, submitted by the company. The Benta Group, in conjunction with an Anglo-Saxon investment fund and a consortium of French banks. Asked by AFP, the Ministry of Industry could not confirm anything on Tuesday morning.

Along with Benta, two large Indian groups, Torrent Pharmaceuticals and Aurobindo Pharma, have been named as possible buyers of the leading generic company in France, as is the British investment company BC Partners. However, the sale of Biogaran has not been officially confirmed and the prospective buyers are refusing to comment.

The vigilant government

In the name of protecting public health, the executive is following the case closely, saying they are ready to take action to keep the generic manufacturer’s operations going. one out of every eight boxes of medicine among those sold in a pharmacy in France. .

118 employees

sell, which took over the Famar site in 2020 in Saint-Genis-Laval, near Lyon at the commercial court bar, manufactures and markets pharmaceuticals , including generics, as well as medical devices. The company Benta Lyon, which belongs to the French holding company Benta SAS, which is owned by the Lebanese investor Bernard Tannoury, has 118 employees, and they expect 24 million euros in turnover this year. Benta Lyon announced in April that it had been launched a new representation of paracetamol in its Saint-Genis-Laval factory with the capacity to produce 80 million boxes of paracetamol per year, a new market for the laboratory that wants to contribute to “strengthening the production of the pharmaceutical industry on the land” national”.

Supply to pharmacies will start next week with the first 300,000 boxes, according to the company which is currently moving six essential molecules in its factory at the same time.